Speakers and Guests: Distinguished guests, students, faculty, and friends.
Sponsors: Berkeley chapter of the bioengineering society and a new group, Out in Science, Technology, Mathematics (O Stem).
Special Tribute: To Ernest S. Kuh, former dean of the college of engineering, professor emeritus, and trailblazer in integrated circuit systems design.
Kuh Lecture Endowment: Made possible by the generosity of Ernie and his wife Patine.
Ernest S. Kuh's Achievements
Impact on Electronics: Pioneering work in the design of integrated circuits (ICs).
Industry Contributions: Co-founded Cadence Design, translating his research into industry.
Academic Contributions: Taught and mentored 40 PhD students, served as Dean of Engineering (1973-1980).
Legacy and Honors: Member of national and Chinese academies of engineering, Silicon Valley Hall of Fame inductee (2008).
Kuh Family
Family Contributions: Sons Tony (electrical engineering chair at University of Hawaii) and Ted (investment banker and faculty at Haas School of Business).
Patine's Support: Recognized for supporting the college.
Keynote: Dr. Andy Grove
Introduction by Chancellor: Andy Grove, a legend in electronics and Silicon Valley, earned his PhD at Berkeley.
Achievements: Founder of Intel Corporation, author of six books, Time Magazine's "Man of the Year".
Social Contributions: Advocate for undocumented students accessing education and jobs.
Medical Contributions: Advanced research on prostate cancer, Parkinson's disease, and created a Master's in Translational Medicine degree program.
Special Recognition: Chancellor's Citation awarded to Andy Grove.
Andy Grove's Lecture Highlights
Title Explanation: Compares speed of medical developments to technology; coined term 'Andy Grove Fallacy'.
Main Issue: Economic impact of slow medical advancements on the US economy.
Key Points on US Medical System
US Life Expectancy vs. Cost: High costs but minimal improvements in life expectancy compared to other countries.
Government Agencies' Roles:
NIH: Responsible for medical science development; prioritization issues.
FDA: Ensures drug safety and effectiveness; lengthy and costly approval process.
Regulatory Overreach: NIH lacks effective project prioritization, FDA's extended responsibility for drug effectiveness leads to high costs.
Big Data in Medicine: Need for open access to large data sets for better medical research and decision-making.
Economic Considerations: Investment and operational costs, comparison to the decline of other industries.
Recommendations:
Facilitate healthcare resource reallocation.
Ensure transparency and data-driven decision-making.
Teach healthcare economics systematically.
Concluding Remarks by Faculty
Gratitude for Andy Grove’s contribution to the forum and insights into healthcare challenges.
Post-Lecture Reception: Hosted by student co-sponsors with gratitude to all attendees.
Questions and Answers
Student Questions: Topics included balancing FDA approval processes, NIH funding arbitrariness, integration of electronic medical records, and government versus private sector roles in healthcare.
Andy Grove's Responses: Emphasized the need for structured judgment and performance evaluations, careful balance of government and private roles in healthcare, and cost-effective medical innovation.
Closing
Expression of Thanks: To Ernie and Patine Kuh for creating the lecture forum, and to Andy Grove for his participation.
Student Co-Sponsors: Bioengineering honors society and OSTEM.
Reception Invitation: Hosted outside in the Garborini Lounge.